Reviva Pharmaceuticals Hldg Inc WT (RVPHW)

$0.12 0.00 (-3.12%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	N/A
Revenue (ttm)	0.00
Net Income (ttm)	-39.26M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	4,100
Avg Vol	17,330
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	40%
Beta	N/A
Analysts	Strong Sell
Price Target	N/A

Company Profile

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity...

Industry: Biotechnology

Sector: Healthcare

Phone: 408-501-8881

Fax: 408-904-6270

Website: www.revivapharma.com

Address:

10080 N. Wolfe Road, Suite SW3-200, Cupertino, United States